Thus, PPARγ is at least partly involved in the pathogenesis of AF by regulation of inflammation through the NF-κB pathway; PPARγ agonist is potential useful in suppressing cardiac fibrosis and preventing AF occurrence. This evidence concerns the gene PPARG and fibrosis.